现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • G-5555 hydrochloride
G-5555 hydrochloride的可视化放大

G-5555 hydrochloride

A PAK1 inhibitor

价格
0-3110
G-5555 hydrochloride的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajcx13912
  • CAS: N/A
  • 别名:
  • 分子式: C25H26Cl2N6O3
  • 分子量: 529.42
  • 纯度: >98%
  • 溶解度: DMSO: 100 mg/mL (188.89 mM); Water: 16.67 mg/mL (31.49 mM)
  • 储存: Store at -20°C
  • 库存: 现货

Background

G-5555 is an inhibitor of p21-activated kinase 1 (PAK1; Ki = 3.7 nM), a non-receptor serine/threonine kinase involved in tumorigenesis.1 It is selective for PAK1 over the majority of targets in a panel of 235 kinases but does inhibit PAK2, PAK3, KHS1, LCK, MST3, MST4, SIK2, and YSK1 by greater than 70% with IC50 values ranging from 9 to 52 nM. G-5555 inhibits phosphorylation of MEK, a downstream target of PAK1, in EBC1 cells (IC50 = 69 nM). G-5555 (10, 20, and 30 mg/kg) dose-dependently reduces phosphorylation of MEK in tumors from an H292 non-small cell lung cancer (NSCLC) mouse xenograft model. G-5555 inhibits hERG channels less than 50% at a concentration of 10 μM, indicating the potential for a low risk of QT interval prolongation and potentially fatal arrhythmias.2


1.Ndubaku, C.O., Crawford, J.J., Drobnick, J., et al.Design of selective PAK1 inhibitor G-5555: Improving properties by employing an unorthodox low-pKa polar moietyACS Med. Chem. Lett.6(12)1241-1246(2015) 2.Braga, R.C., Alves, V.M., Silva, M.F., et al.Tuning HERG out: Antitarget QSAR models for drug developmentCurr. Top. Med. Chem.14(11)1399-1415(2014)

Protocol

Kinase experiment:

The 10 ?L assay mixtures contain 50 mM HEPES (pH 7.5), 0.01% Brij-35, 10 mM MgCl2, 1 mM EGTA, 2 ?M FRET peptide substrate, and PAK enzyme (20 pM PAK1; 50 pM PAK2; 90 pM PAK4). Incubations are carried out at 22°C in black polypropylene 384-well plates. Prior to the assay, enzyme, FRET peptide substrate and serially diluted test compounds (G-5555) are preincubated together in assay buffer (7.5 ?L) for 10 minutes, and the assay is initiated by the addition of 2.5 ?L assay buffer containing 4x ATP (160 ?M PAK1; 480 ?M PAK2; 16 ?M PAK4). Following the 60-minute incubation, the assay mixtures are quenched by the addition of development reagent, and 1 hour later the emissions of Coumarin (445 nm) and Fluorescein (520 nm) are determined after excitation at 400 nm using an Envision plate reader[1].

Animal experiment:

Mice: 3 mice in each of the two groups are administered 25 mg/kg oral suspension dose twice, with the second dose given 6 hours after the first dose. The dose volumes are 5 mL/kg for the IV group and 10 mL/kg for the PO groups. Following administration of G-5555 (12), 15 ?L of blood is collected at each time point are stored at -70 to -80°C until analysis[1].

参考文献:

[1]. Ndubaku CO, et al. Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety. ACS Med Chem Lett. 2015 Oct 31;6(12):1241-6.
[2]. Rudolph J, et al. Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window. J Med Chem. 2016 Jun 9;59(11):5520-41.

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服